Burning Rock Biotech Ltd
جودة البيانات: 100%
BNR
NASDAQ
Services
Health Services
KWD 22.50
▲
KWD 1.94
(9.44%)
6 months return
—
Momentum
Neutral
5Y revenue growth
1.77%
النمو
Revenue Growth (5Y)
1.77%
أقل من متوسط القطاع (3.76%)
Revenue (1Y)-6.64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-50.57%
أقل من متوسط القطاع (-16.21%)
ROIC-39.86%
Net Margin-67.20%
Op. Margin-69.32%
الأمان
Debt / Equity
0.00
أقل من متوسط القطاع (0.39)
Current Ratio4.07
Interest CoverageN/A
التقييم
PE (TTM)
-3.72
أقل من متوسط القطاع (-1.17)
P/B Ratio0.83
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 1.77% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -13.38 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.41%
Capital efficient — spends only 1.05% of revenue on capex
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
مفاجآت الأرباح
EPS
Reported
Estimate
| Q22022 | Q32022 | Q42022 | Q12023 | |
|---|---|---|---|---|
| Reported | -KWD 25.00 | -KWD 23.30 | -KWD 21.10 | -KWD 18.10 |
| Estimate | -KWD 18.50 | -KWD 18.80 | -KWD 19.00 | -KWD 13.90 |
| المفاجأة | -35.14% | -23.94% | -11.05% | -30.22% |
Growth
Rev 5Y: 1.77% · Earnings 1Y: N/A
Growth
Rev 5Y: 1.77% · Earnings 1Y: N/A| Revenue Growth (1Y) | -6.64% | Revenue Growth (3Y) | -6.98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.77% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -50.57% · Net Margin: -67.20%
Profitability
ROE: -50.57% · Net Margin: -67.20%| Revenue (TTM) | 70.67 M | Net Income (TTM) | -47.49 M |
| ROE | -50.57% | ROA | -35.47% |
| Gross Margin | 70.25% | Operating Margin | -69.32% |
| Net Margin | -67.20% | Free Cash Flow (TTM) | -13.38 M |
| ROIC | -39.86% | FCF Growth (3Y) | N/A |
Safety
D/E: 0.00 · Current: 4.07
Safety
D/E: 0.00 · Current: 4.07| Debt / Equity | 0.00 | Current Ratio | 4.07 |
| Interest Coverage | N/A | Asset Turnover | 0.53 |
| Working Capital | 164.77 M | Tangible Book Value | 213.33 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -3.72 · EV/EBITDA: N/A
Valuation
P/E: -3.72 · EV/EBITDA: N/A| P/E Ratio | -3.72 | Forward P/E | N/A |
| P/B Ratio | 0.83 | P/S Ratio | 2.50 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7.57% | ||
| Market Cap | 176.79 M | Enterprise Value | 5.66 M |
Per Share
EPS: N/A · FCF/Share: -1.24
Per Share
EPS: N/A · FCF/Share: -1.24| EPS (Diluted TTM) | N/A | Revenue / Share | 6.56 |
| FCF / Share | -1.24 | OCF / Share | -1.17 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 28.18% · CapEx/Rev: 1.05%
Efficiency
FCF Conv: 28.18% · CapEx/Rev: 1.05%| CapEx / Revenue | 1.05% | FCF Conversion | 28.18% |
| SBC-Adj. FCF | -34.70 M | Growth Momentum | -8.41 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 70.67 M | 75.70 M | 81.66 M | 79.69 M | 65.89 M |
| Net Income | -47.49 M | -92.07 M | -140.82 M | -125.02 M | -62.41 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 49.65 M | 51.16 M | 55.10 M | 57.14 M | 48.11 M |
| Operating Income | -48.99 M | -94.27 M | -142.15 M | -125.08 M | -63.21 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 31.82 M | 48.88 M | 61.17 M | 57.73 M | 40.45 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 7.15 M | 18.79 M | 17.99 M | 7.50 M | 5.11 M |
| Interest Expense | 0.0 | 0.0 | 15,000.0 | 241,000.0 | 102,000.0 |
| Income Tax | 806,000.0 | 336,000.0 | 288,000.0 | 141,000.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 121.29 M | 146.48 M | 230.16 M | 357.56 M | 408.13 M |
| Total Liabilities | 41.71 M | 38.25 M | 62.22 M | 67.99 M | 37.09 M |
| Shareholders' Equity | 79.57 M | 108.23 M | 167.94 M | 289.57 M | 371.04 M |
| Total Debt | — | — | 0.0 | 372,000.0 | 1.13 M |
| Cash & Equivalents | 71.22 M | 86.63 M | 131.28 M | 224.61 M | 290.47 M |
| Current Assets | 106.40 M | 124.52 M | 182.50 M | 285.75 M | 386.77 M |
| Current Liabilities | 36.48 M | 37.10 M | 59.66 M | 58.41 M | 37.02 M |
مقارنة الأقران
مقابل وسيط قطاع Services (615 نظير)
مقارنة بشركات مشابهة في Services
مقارنة الأقران
مقابل وسيط قطاع Services (615 نظير) مقارنة بشركات مشابهة في Services| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.7 | -1.2 |
| P/B | 0.8 | 1.4 |
| ROE % | -50.6 | -16.2 |
| Net Margin % | -67.2 | -19.4 |
| Rev Growth 5Y % | 1.8 | 3.8 |
| D/E | 0.0 | 0.4 |
{"event":"ticker_viewed","properties":{"ticker":"BNR","listing_kind":"stock","pathname":"/stocks/bnr","exchange":"NASDAQ","country":"US"}}